Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine vs Gemcitabine + TS-1 in Advanced Pancreatic Cancer
NCT00514163Phase 2Completed
- Sponsor
- Japan Clinical Cancer Research Organization
- Start
- Jun 2007
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of tegafur in pancreatic cancer (PC) (2 arms), sponsored by Japan Clinical Cancer Research Organization. Primary endpoint: Tumor Response Rate. Started Jun 2007; status: completed.
02
Drugs
tegafur
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00514163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00514163.